Corcept Therapeutics (CORT) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update
November 1, 2016 4:05 PM EDTMENLO PARK, CA -- (Marketwired) -- 11/01/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
Financial Highlights
Third quarter revenue of $21.7 million, a 64 percent increase from the third quarter of 2015 Third quarter GAAP net income of $0.02 per share, compared to a GAAP net loss of $0.01 per share in the third quarter of 2015 Excluding non-cash expenses, third quarter non-GAAP net income of $0.04 per share, compared to non-GAAP net income of $0.02 per share in the third quarter of 2015 Company increases 2016 revenue guidance to $79-82 million Cash balance at September 30, 2016 increases to... More